FindTrial
Sign In

Valacyclovir hydrochloride

DRUG15 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Glaxo Wellcome, GlaxoSmithKline, Astellas Pharma Inc, National Eye Institute (NEI)

Conditions

ChickenpoxCytomegalovirus InfectionsGenital HerpesHIV InfectionsHealthyHerpes GenitalisHerpes SimplexHerpes Zoster

Phase 1

The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children
WithdrawnNCT00001054
National Institute of Allergy and Infectious Diseases (NIAID)Chickenpox, Herpes Simplex, HIV Infections
End: 2001-01-31Updated: 2021-11-04
30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers
NCT00587496
National Eye Institute (NEI)Herpes Simplex
Start: 2006-04-30End: 2008-07-31Target: 60Updated: 2008-01-07
Bioavailability Study of Valacyclovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fasting Conditions
CompletedNCT01136525
Dr. Reddy's Laboratories LimitedHealthy
Start: 2007-02-28End: 2007-05-31Updated: 2010-06-14
Bioavailability Study of Valacycovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fed Condition
CompletedNCT01136538
Dr. Reddy's Laboratories LimitedHealthy
Start: 2007-02-28End: 2007-05-31Updated: 2010-06-14

Phase 2

Dose-finding Study of ASP2151 in Subjects With Herpes Zoster
CompletedNCT00487682
Astellas Pharma IncHerpes Zoster
Start: 2007-11-13End: 2008-09-01Updated: 2018-11-23

Phase 3

A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients
NCT00005663
Glaxo WellcomeHerpes Genitalis, Herpes Simplex, HIV Infections
Start: 1999-06-30Updated: 2005-06-24
A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients
CompletedNCT00001038
National Institute of Allergy and Infectious Diseases (NIAID)Cytomegalovirus Infections, HIV Infections
Target: 1200Updated: 2011-03-01

Phase 4

A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons
TerminatedNCT00079911
GlaxoSmithKlineHerpes Genitalis
Start: 2004-03-12End: 2004-10-15Updated: 2020-11-24

Unknown Phase

The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected Patients
CompletedNCT00002404
Glaxo WellcomeHerpes Simplex, HIV Infections
Target: 30Updated: 2008-01-29
A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients
CompletedNCT00002084
Glaxo WellcomeHerpes Simplex, HIV Infections
Updated: 2005-06-24
A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients
CompletedNCT00002000
Glaxo WellcomeHerpes Simplex, HIV Infections
Updated: 2005-06-24
Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions
CompletedNCT01132716
Roxane LaboratoriesGenital Herpes, Herpes Zoster, Shingles
Start: 2006-09-30End: 2006-09-30Updated: 2018-01-23
Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting Conditions
CompletedNCT01132729
Roxane LaboratoriesGenital Herpes, Herpes Zoster, Shingles
Start: 2006-09-30End: 2006-09-30Updated: 2018-01-23
A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fasting Condition
CompletedNCT01222910
Ranbaxy Laboratories LimitedHealthy
Start: 2009-05-31End: 2009-07-31Updated: 2010-10-18
A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fed Condition
CompletedNCT01222897
Ranbaxy Laboratories LimitedHealthy
Start: 2009-05-31End: 2009-07-31Updated: 2010-10-18